Peri-implant Papillary Height Comparison in Microsurgically and Macrosurgically Placed Dental Implants

Clinical and Radiological Comparison of Peri Implant Soft Tissue Parameters and Crestal Bone Loss Around Microsurgically and Macrosurgically Placed Implants: A Randomised Controlled Clinical Trail

This study compares the peri-implant soft tissue and crestal bone loss around single implants when placed macrosurgically and microsurgically.

Study Overview

Detailed Description

Black triangles in dentition especially in the anterior teeth would pose an esthetic concern. Interdental papilla height is crucial for eliminating this black triangle.

32 participants, 16 in two groups were assigned randomly. Microsurgical approach using microsurgical instruments and magnifying loupes were used for one group participants and similar procedure without magnifying loupes and microsurgical instruments was done in the other group.

comparsion of the microsurgical outcome is done by measuring peri implant papilla gain and radiographic crestal bone loss will be done between the groups.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Karnataka
      • Bangalore, Karnataka, India, 562157
        • Krishnadevaraya college of dental sciences and hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients desiring implant placement for replacement of missing tooth and willing to participate in the study

    • Non smokers
    • Patients who do not report any relevant medically comprimising conditions or had not received any radiation therapy in head and neck region for cancer therapy.
    • Subjects with satisfactory residual ridges who demonstrated adequate bucco-lingual and mesio-distal space for implant placement, that facilitates primary stability.
    • Patients who demonstrate Plaque Index <10% and good compliance.
    • Full mouth bleeding scores ≤25% before the implant placement.
    • Sites with sufficient band of keratinised mucosa.

Exclusion Criteria:

  • • Pregnant and lactating females

    • Patients on anticancer therapy and immunosuppressant drugs.
    • Implants to be placed in sites with previous periodontal disease
    • Bleeding disorder or on anticoagulant therapy
    • Systemic diseases that would negatively influence wound healing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: control group
conventional macrosurgical implant placement
macrosurgical placement of single dental implants
EXPERIMENTAL: test group
microsurgical implant placement
microsurgical dental implant placement employin splt finger technique by Misch

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
peri-implant papilla height
Time Frame: 1 year
mesial and distal peri implant papilla height is measured in millimeter
1 year
marginal gingiva
Time Frame: 1 year
buccal marginal gingival height is measured
1 year
jemt papilla index
Time Frame: 1 year

papillary height gained around implant is scored using jemt papilla index 0 = no papilla and no indication of a curvature of the soft tissue adjacent to the implant crown are present;

  1. = less than one-half of the papilla height is present, and a convex curvature of the soft tissue adjacent to the implant crown and adjacent tooth can be observed;
  2. = at least one-half of the papilla height is present but not to the contact point between the teeth, the papilla is not completely harmonious with the adjacent papillae between the permanent teeth, and soft tissue is harmonious with adjacent teeth;
  3. = the papilla fills the entire proximal space and is harmonious with the adjacent papillae, and soft-tissue contour is optimal;
  4. = the papillae are hyperplastic and cover too much of the implant or the adjacent tooth, and the soft-tissue contour is irregular
1 year
crestal bone loss
Time Frame: 1 year
radiographic crestal bone level around the implants measured from 1st thread of the implant to the coronal or apical most bone level in millimeters.
1 year
pink esthetic score
Time Frame: 1 year
scoring assigned to 7 soft tissue criteria by an examiner as 0,1,2,3 and the average of the total score is considered the final score. a maximum score of 14 can be alloted
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
surgical time taken
Time Frame: 1 day
the time taken right from the incision to the implant placement is watched and recorded.
1 day
visual analogue scale score
Time Frame: 1 year
aesthetic score by the outcome investigator using VAS score sheet of 10 points. 1 being most painful and 10 being painless
1 year
probing depth
Time Frame: 1 year
peri implant probing depth at each follow up was recorded
1 year
plaque index
Time Frame: 1 year
plaque scores were recorded at each follow up 0.-0.9 good 1.0-1.9-fair 2-3-poor
1 year
gingival index
Time Frame: 1 year
gingival index scores were recorded at each followup 0.1-1-mild gingivitis 1.1-2- moderate gingivitis 2.1-3 severe gingivitis
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dr.Joann pauline George, MDS, Krishnadevaraya college of dental sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 10, 2017

Primary Completion (ACTUAL)

September 30, 2019

Study Completion (ACTUAL)

September 30, 2019

Study Registration Dates

First Submitted

December 4, 2019

First Submitted That Met QC Criteria

December 5, 2019

First Posted (ACTUAL)

December 6, 2019

Study Record Updates

Last Update Posted (ACTUAL)

December 10, 2019

Last Update Submitted That Met QC Criteria

December 6, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 02_D012_82168

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Implants

Clinical Trials on macrosurgical dental implant placement

Subscribe